LIFE SCIENCES
Challenges facing the life sciences sector
The pace of change in the life sciences industry has never been greater. Companies are under pressure to keep up with significant levels of market activity including M&A, technological advancement coupled with enhanced customer expectations, and heightened disruption from non-traditional competitors. At Gate One, we have a strong track record of patient-centric transformations in the life sciences sector, helping organisations to overcome these challenges.
M&A turmoil
For many organisations, M&A is a means of quickly gaining a competitive edge. The right opportunity enables life sciences businesses to accelerate research and development (R&D), while restocking their shrinking product pipelines. However, merging, acquiring, separating or divesting all come with their own unique challenges. Anticipating and resolving these quickly is critical to preserving shareholder value.
Technological advancement
To stay ahead of the curve and satisfy customer expectations, organisations need to be able to deliver tailored therapies, support solutions and customer engagement (patient and HCP) – all of which are heavily dependent on optimising data and a wide variety of digital and technology solutions. The regulatory backdrop presents further complexity that must be factored into both design and delivery.
Non-traditional competitors
Disruption from non-traditional competitors is increasing the size and complexity of the industry. This is driving organisations to shift from a more focused portfolio approach to patient and customer-centric innovation, which brings with it the need to design, implement and optimise new working practices.
Our Credentials
We are privileged to be working with some of the largest and most influential life sciences organisations on their complex change programmes. View some of our client stories here.
Delivering a multi-billion-pound acquisition and integration
Defining and regionally implementing integration support activities as part of a major pharmaceutical acquisition.
Driving global growth through digital for a global pharma
Setting the strategy and delivering the rollout of a new customer engagement system with world-class technology.
Stepping up marketing
Establishing an integrated data-driven marketing capability to deliver improved ROI and smarter ways of working.
”With Gate One, project onboarding is very easy and the team embed very effectively - they roll their sleeves up and get into the detail of delivery really effectively.
Stephen WrightHead of transformation PMO at GSK Consumer Health
Meet some of our team
Pamela is a life sciences value creation, strategic growth and acquisition advisory specialist focused on delivering impressive outcomes for businesses, their employees and their customers. She has a PhD in medical sciences and an executive MBA (both from the University of Oxford). Her career spans drug development, strategy and management consulting within the global healthcare and pharmaceutical arenas.
Umbar possède une vaste expérience intersectorielle dans des domaines tels que les biens de consommation, le secteur public/le logement et les sciences de la vie, où elle a aidé plusieurs sociétés pharmaceutiques à favoriser l’implication des clients. De la stratégie à l’innovation numérique, des villes intelligentes à l’automatisation intelligente, en passant par l’implication des clients et la mise en disposition de technologies flexibles, Umbar est passionnée par le numérique et sa capacité à aider les organisations et les clients.
Anna has extensive experience working across the private, public and third sector to support clients in designing and delivering innovative, intelligent operating models for their customers. Anna has led and managed numerous projects in a range of settings, allowing her to develop an understanding of perspectives that range from the end user to frontline staff and senior leadership.
Pamela is a life sciences value creation, strategic growth and acquisition advisory specialist focused on delivering impressive outcomes for businesses, their employees and their customers. She has a PhD in medical sciences and an executive MBA (both from the University of Oxford). Her career spans drug development, strategy and management consulting within the global healthcare and pharmaceutical arenas.
Anthony is the country manager for Gate One Ireland. He has nearly 20 years’ experience working with leading global organisations, delivering change across M&A, innovation, commercial excellence and digital transformation. He is an experienced consultancy leader and board member and has worked extensively across the public and private sectors in the UK, Europe and the Middle East. Anthony is extremely excited about the opportunity to build and grow a new and truly differentiated consultancy in Ireland – serving global and Irish clients alike.
Niamh is an experienced transformation consultant, with over 10 years experience empowering organisations through strategic transformation, encompassing digital advancements, data utilisation, people-centric approaches, culture, and structural enhancements. Her interests lie in supporting change delivery, that revolves around the needs and experiences of users. Niamh brings a comprehensive skill set in change and project management, which she has developed working with both local and global, public and private sector organisations, in successfully executing transformational initiatives and programmes throughout her career.
Clare is an experienced consultant who has worked across the end-to-end delivery lifecycle. Her passion lies in putting people at the heart of digital strategies and transformations to create empowering change for people, be they consumers or employees. Clare has experience in developing innovation operating models, service design, design thinking and people-led change management.
Pamela is a life sciences value creation, strategic growth and acquisition advisory specialist focused on delivering impressive outcomes for businesses, their employees and their customers. She has a PhD in medical sciences and an executive MBA (both from the University of Oxford). Her career spans drug development, strategy and management consulting within the global healthcare and pharmaceutical arenas.
Hannah has significant experience in life sciences and leads our US life sciences team. She has worked with global pharmaceutical companies to set their strategy, prepare for product launches, and deliver large-scale transformation to improve their customer experience. She is passionate about helping organizations optimize their strategy and operations to transform the lives of patients.
Umbar is our digital and data lead. She has extensive cross-sector experience across consumer business, public sector/housing and life sciences, where she has supported several global pharmaceutical businesses dramatically enhance their customer engagement. From strategy and digital innovation, smart cities to intelligent automation, and customer engagement to Agile technology delivery, Umbar is passionate about digital and its power to help organisations and customers alike.
If you would like to speak to us about how we can help you deliver value to your customers, please contact Dr Pamela Walker Geddes.
If you would like to speak to us about how we can help you deliver value to your customers, please contact Anthony Gaffney.
If you would like to speak to us about how we can help you deliver value to your customers, please contact Hannah Caldwell.
